MediWound Ltd. announced the appointment of Aharon Yaari to the company's Board of Directors. With this change, the company's Board of Directors increases to seven members, while the composition of the Board's committees remain unchanged. Since 2015, Mr. Yaari has served as a director of Clal Biotechnology Industries Ltd.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.86 USD | -10.85% | -9.94% | +55.95% |
May. 29 | Transcript : MediWound Ltd., Q1 2024 Earnings Call, May 29, 2024 | |
May. 29 | Earnings Flash (MDWD) MEDIWOUND Reports Q1 Revenue $5M, vs. Street Est of $4.7M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.95% | 165M | |
-3.30% | 90.75B | |
-4.34% | 39.03B | |
-17.08% | 31.85B | |
+61.22% | 26.26B | |
-22.15% | 14.13B | |
-9.36% | 12.87B | |
-11.39% | 11.6B | |
-46.06% | 10.91B | |
+2.17% | 8.89B |
- Stock Market
- Equities
- MDWD Stock
- News MediWound Ltd.
- MediWound Ltd. Appoints Aharon Yaari to its Board of Directors